Latest hum. ProductsDetails
Product Name in the RMS: Bortezomib Glenmark 3,5 mg
MR Number: NL/H/3178/002
Date of outcome: 27.05.2015
| Type of application | |
|---|---|
|
Level 1: Level 2: Level 3: Level 4: Level 5: |
Abridged Additional Strength/Form Generic Chemical Substance Prescription Only |
| Active Substances |
BORTEZOMIB 3,5 mg |
| Form | Powder for solution for injection |
| MA Holder in the RMS |
Glenmark Pharmaceuticals s.r.o., City Tower, Hvezdova 1716/2b, 140 78 Prague 4, Czech Republic |
| RMS | Netherlands |
| Date of last change | 02.06.2021 |
| ATC-Code |
L01XX32 Bortezomib |
| CMS Country | Domestic Product Name |
|---|---|
| Czech Republic | BORTEZOMIB GLENMARK 3,5 MG |
| Poland | Bortezomib Glenmark |
| Romania | Bortezomib Glenmark 3,5 mg pulbere pentru solutie injectabila |
| Slovak Republic | Bortezomib Glenmark 3,5 mg |
| Documents | |
|---|---|
| PAR: | NL_H_3178_002_PAR.pdf (23.03.2016) |
| PARSummary: | NL_H_3178_002_PARSummary.pdf (23.03.2016) |
| FinalPL: | NL_H_3178_002_FinalPL.pdf (11.01.2018) |
| FinalLabelling: | NL_H_3178_002_FinalLabelling_1of3.pdf (11.01.2018) |
| FinalLabelling: | NL_H_3178_002_FinalLabelling_2of3.pdf (11.01.2018) |
| FinalLabelling: | NL_H_3178_002_FinalLabelling_3of3.pdf (11.01.2018) |
| Finalised Product Information: | NL_H_3178_002_FinalPI_1of4.pdf (27.05.2019) |
| Finalised Product Information: | NL_H_3178_002_FinalPI_2of4.pdf (27.05.2019) |
| Finalised Product Information: | NL_H_3178_002_FinalPI_3of4.pdf (27.05.2019) |
| Finalised Product Information: | NL_H_3178_002_FinalPI_4of4.pdf (27.05.2019) |
